Nasdaq

Scilex Holding Company Reports ZTlido® Associated with Reduced Opioid Use Compared to 5% Lidocaine Patch in Recent Study

Scilex Holding Company announced the publication of a study in Pain Medicine News revealing that patients treated with ZTlido® (lidocaine topical system 1.8%) showed a greater reduction in opioid use ...
Healio

FDA issues warning for OTC topical pain relievers with high levels of lidocaine

Please provide your email address to receive an email when new articles are posted on . The FDA has issued warnings to six companies for the marketing of analgesics with unlawful lidocaine ...
Frontiers

SOOTHER TRIAL: Observational study of an over-the-counter ointment to heal anal itch

Introduction: Pruritus ani, or rectal or anal itch, is a common perianal disorder that affects ~5% of the population of the developed world. Treatments for this disorder are somewhat limited and ...
Frontiers

Local Anesthetic Lidocaine and Cancer: Insight Into Tumor Progression and Recurrence

1 Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, China 2 Ambulatory Surgery Center, The First Affiliated Hospital of Anhui Medical University, Hefei, ...
BioSpace

Teligent Announces FDA Approval Of Triamcinolone Acetonide Ointment USP, 0.5%

BUENA, N.J., March 6, 2017 /PRNewswire/ -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's ...
BioSpace

Teligent Announces FDA Approval Of Lidocaine Ointment USP 5%

BUENA, N.J., Feb. 2, 2016 /PRNewswire/ -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's ...